Follow the Indegene Limited share price and the full insider trade history of the company, a listed equity based in India. Shares are listed on IN IN, under the supervision of SEBI (PIT + SAST). Operating in the Health Care sector, Indegene Limited has recorded 21 insider filings. Market capitalisation: €126.4bn. The latest transaction was disclosed on 20 March 2026 (Purchase). Among the most active insiders: BINA PATIL. The full history is openly available.
21
Insider Decl.
0
Thresholds
€1m
6 ops.
Buy Volume
€1m
15 ops.
Sell Volume
24Σ signal
Buys €1m€1m Sells
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 6,602 of 25,921 companies
63.9
score / 100
Value
49
Quality
79
FCF yld5.1%
Earn yld3.3%
EV/EBITDA18.1x
ROE14%
Gross mgn·
Net mgn11%
Debt/EBITDA0.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.